Regulatory Authority points out errors to CHUA in the event of the death of a cancer patient

"The process of the user was, unjustifiably, on hold", considers the ERS

Credits: Depositphotos

The Health Regulatory Authority points the finger at the Hospital and University Center of the Algarve (CHUA) in the case of a cancer patient who died without even starting chemotherapy treatments, in March of this year. 

ERS released this Wednesday, November 27, a report which contains the resolutions completed during the third quarter of 2019.

In this case, the Entity states that, although the user had a biopsy at CHUA, on January 8, with a view to later carrying out an examination to detect mutations in the EGFR gene, at the Lisbon IPO, this request only was sent, by the Hospital and University Center of the Algarve, 15 days later.

The request ended up being "returned for lack of sufficient information (which should have been included in the Term of Liability), and CHUA only returned a new request for examination on February 21st, to which the IPO responded on February 27th" , frame.

Based on these data, the Health Regulatory Authority does not shy away from pointing blame to CHUA. "The patient's case was, unjustifiably, suspended, as the results of the biopsy were simply not diligently sent by CHUA to IPOLFG", he considers.

This attitude, in the opinion of this entity, reveals "deficient processing and streamlining of processes" since "it caused serious damage to the prospective definition of a therapeutic strategy for the user".

Added to this is the fact that CHUA has recognized “the lack of means to carry out the examinations in question and the possibility of an indefinite number of users in the same situation”.

In this regard, the Health Regulatory Authority issued an order to the University Hospital Center of the Algarve to inform, "with full identification of the names and respective situations, the number of users, for each hospital unit, who are waiting, and for how long time, for the performance of exams and MCDT of the forum
oncology'.

The ERS also wants to know what measures have been taken so that these tests "are carried out in external entities as soon as possible". The objective is to prevent new situations like this from happening again.

This case of cancer patients who were untreated in the Algarve, some ending up dying, was denounced by deputy Cristóvão Norte (PSD), in May this year.

Comments

Ads